FAPI PET/CT provides higher uptake and better target to back ground in recurrent and metastatic tumors of patients with Iodine refractory papillary thyroid cancer compared with FDG PET CT
CONCLUSION: FAPI accumulates in the recurrent and metastatic lesions of patients with Iodine refractory PTC at least as well as FDG with particular privileges as lower injected activity and lower back ground.PMID:38190996 | DOI:10.1055/a-2185-7746
Source: Nuklearmedizin - Category: Radiology Authors: Shaghayegh Nourbakhsh Yalda Salehi Saeed Farzanehfar Reza Ghaletaki Mohsen Bakhshi Kashi Mehrshad Abbasi Source Type: research
More News: Cancer | Cancer & Oncology | CT Scan | Iodine | Liver | PET Scan | Radiology | Study | Thyroid | Thyroid Cancer | Urology & Nephrology